Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19
Over the past several decades, its prevalence has risen at an alarming rate worldwide, reaching pandemic proportions and showing no signs of stabilization [1, 2]
Clinicians may consider weekly versus daily GLP-1 formulations for patients who experience sensitivity
ECC5004 is in a Phase 1 clinical trial in the U.S
Through genome-resolved metagenomics and targeted isolation, we investigate ecological interactions and selective pressures that shape contamination pathways
US$ 21.62
US$ 29.62
US$ 22.45
